The CDC released the first set of new STI guidelines since 2015. What are the notable updates that primary care physicians should know? Find out here.
The US Centers for Disease Control and Prevention (CDC) released its Sexually Transmitted Infections (STI) Treatment Guidelines 2021, the first update since 2015. In the slides below, find 7 key updates for primary care physicians from the new guidelines, including new treatment recommendations for chlamydia and gonorrhea.
The new CDC guidelines recommend doxycycline 100 mg orally twice daily for 7 days as first-line chlamydial infection treatment for adolescents and young adults.
Due to the emergence of azithromycin resistance, dual treatment for gonococcal infection is no longer recommended. The CDC now recommends ceftriaxone 500 mg IM in a single dose for the treatment of uncomplicated gonorrhea of the cervix, urethra, and rectum in adults and adolescents weighing less than 150 kg.
The recommended treatment in adults and adolescents with uncomplicated gonorrhea of the pharynx is ceftriaxone 500 mg IM in a single dose for patients weighing less than 150 kg and 1 g for those weighing more than 150 kg.
The new recommended treatment for trichomoniasis differs for men and women. For women, the recommend regimen is metronidazole 500 mg orally twice daily for 7 days and metronidazole 2 g orally in a single dose for men.
The CDC now recommends the addition of metronidazole to all pelvic inflammatory disease treatment regimens.